Co-Immunoprecipitation (Co-IP) Protocol: Protein-Protein Interaction Workflow

Co-immunoprecipitation (Co-IP) is an antibody-based method for isolating a protein of interest together with proteins that remain associated with it under the chosen lysis and wash conditions. Unlike a standard immunoprecipitation used mainly to enrich one target, Co-IP is designed to preserve and interrogate protein–protein interactions. The method is widely used to validate candidate interactors, study signalling complexes, compare interaction changes after stimulation or drug treatment, and prepare native complexes for western blotting or mass spectrometry.

The central challenge is balance: the lysate must be strong enough to solubilise the bait protein, but gentle enough to preserve the interaction being studied. There is therefore no single universal Co-IP buffer or wash condition. Antibody quality, detergent choice, salt concentration, sample handling, bead chemistry and incubation time all influence which interactions survive the workflow.

Use this protocol as a starting framework. If the antibody or reagent supplier provides validated Co-IP conditions, those conditions should take precedence. For membrane proteins, transient interactions or low-abundance complexes, optimise lysis and wash stringency empirically.

What does Co-IP measure?

Co-IP does not directly prove that two proteins bind each other physically. It demonstrates that the proteins can be recovered in the same biochemical complex under the experimental conditions used. A detected interaction may be direct, mediated by another protein, stabilised by nucleic acid, or dependent on a larger multiprotein assembly.

For that reason, strong Co-IP conclusions normally combine the assay with appropriate controls and, where important, an orthogonal method such as reciprocal Co-IP, affinity pull-down, proximity-based methods, FRET/BRET, mutational mapping or mass spectrometry.

When to use Co-IP

• Validate a suspected protein–protein interaction identified by literature, proteomics or screening.
• Test whether a signalling complex forms after ligand stimulation, inhibitor treatment or genetic perturbation.
• Compare interaction strength or complex composition between conditions.
• Confirm that two endogenous proteins associate without overexpression.
• Recover a native complex before western blotting or LC–MS/MS.
• Map interaction domains by comparing wild-type and mutant constructs.
• Assess whether an interaction is sensitive to salt, detergent, phosphorylation state or nucleic-acid digestion.

Equipment required

• Refrigerated microcentrifuge.
• Tube rotator or end-over-end mixer suitable for 4°C use.
• Magnetic rack for magnetic beads, or centrifuge compatible with agarose bead recovery.
• Ice bucket and pre-chilled tubes.
• Calibrated pipettes and low-retention tips.
• Protein quantification reagents such as BCA or Bradford assay reagents.
• SDS-PAGE and western blot equipment for targeted validation, or access to mass spectrometry for discovery analysis.

Reagents and materials

• Cells or tissue containing the bait protein and expected interaction partner.
• Ice-cold non-denaturing lysis buffer.
• Protease inhibitors; include phosphatase inhibitors when phosphorylation-dependent interactions are being studied.
• Target-specific antibody suitable for immunoprecipitation.
• Species- and isotype-matched non-specific IgG control.
• Protein A, Protein G or Protein A/G magnetic or agarose beads appropriate for the antibody isotype.
• Wash buffer, usually based on the lysis buffer with controlled detergent and salt composition.
• Elution reagent: SDS sample buffer for denaturing analysis, or a gentler low-pH/competitive method when native recovery is required.

Choosing the lysis buffer

Co-IP usually begins with a mild, non-denaturing buffer. NP-40, Triton X-100 or related non-ionic detergents are commonly used because they solubilise many proteins while preserving a substantial fraction of native complexes. Harsher detergents, high salt, reducing agents and chaotropes can disrupt the interaction you are trying to measure.

A practical optimisation strategy is to start with a mild buffer and increase stringency only if background is problematic. Membrane-associated baits may require a stronger or different detergent than soluble cytosolic proteins. If the interaction is known to be weak or transient, minimise time, keep the sample cold and avoid unnecessary mechanical stress.

Before starting

• Confirm that the bait and prey proteins are detectable in the starting material.
• Check that the antibody is reported or experimentally shown to work in IP/Co-IP. An antibody that works in western blot does not automatically work in IP.
• Plan an input lane, IgG control and ideally a beads-only control.
• For a new interaction, plan a reciprocal Co-IP if a suitable antibody to the prey is available.
• Pre-chill buffers and keep samples on ice or at 4°C.
• Record antibody lot, bead type, total lysate input, detergent composition, salt concentration and wash conditions for reproducibility.

Detailed Co-IP protocol

1. Prepare cells or tissue. Harvest the experimental sample using conditions that preserve the biological state of interest. For treatment studies, collect control and treated samples in parallel and keep handling time consistent.
2. Wash with cold PBS. Remove residual culture medium or serum proteins that could contribute background.
3. Lyse gently. Add ice-cold non-denaturing lysis buffer containing fresh protease inhibitors. Incubate on ice or at 4°C with gentle mixing, typically for 15–30 minutes. Avoid vigorous vortexing if preserving fragile complexes.
4. Clarify the lysate. Centrifuge at high speed at 4°C to pellet insoluble material. Transfer the supernatant to a fresh pre-chilled tube without disturbing the pellet.
5. Measure protein concentration. Quantify total protein so equivalent lysate inputs can be used across conditions. Normalising lysate input is important when comparing interactions between samples.
6. Reserve input material. Remove approximately 1–5% of each lysate for an input control. Store appropriately until western blot analysis.
7. Optional: pre-clear the lysate. Incubate with plain beads or control IgG plus beads for 30–60 minutes at 4°C. Remove the beads and retain the pre-cleared supernatant. Pre-clearing can reduce non-specific background but may also remove genuine interactors, so it should be used consistently once adopted.
8. Add the bait-specific antibody. Use an amount supported by the antibody supplier or determine an empirical titration. A common starting range for many IP antibodies is a few micrograms per reaction, but the required amount varies widely with affinity, abundance and lysate volume.
9. Incubate at 4°C with rotation. Binding can be performed for 1–4 hours or overnight. Longer incubation may improve recovery of low-abundance bait but can also increase non-specific binding.
10. Add Protein A/G beads. Wash or equilibrate beads according to the manufacturer’s instructions before use. Add sufficient bead capacity for the antibody quantity used.
11. Capture immune complexes. Rotate at 4°C, commonly for 1–2 hours. Avoid excessive bead loading, which can raise background.
12. Collect the beads. Use a magnetic rack for magnetic beads or gentle centrifugation for agarose beads. Remove the supernatant carefully.
13. Wash the beads. Wash at least three times with cold wash buffer. Resuspend beads fully during each wash. If background is high, increase salt concentration, detergent concentration or wash number gradually rather than making the entire protocol harsh at once.
14. Final wash. Remove residual wash buffer thoroughly while avoiding over-drying of the bead pellet.
15. Elute bound complexes. For routine western blotting, add reducing SDS sample buffer and heat according to the downstream protocol. For native recovery or mass spectrometry, consider a compatible low-pH, competitive peptide or tag-specific elution method.
16. Analyse bait and prey. Resolve eluates by SDS-PAGE. Western blot first for the bait to confirm successful IP, then probe for the expected interacting protein. For discovery workflows, submit an appropriate control-matched eluate for LC–MS/MS.

Essential controls

Input

The input confirms that bait and prey were present in the starting lysate. If the prey is absent from input, failure to detect it in Co-IP is not informative.

IgG control

Use non-specific IgG from the same host species and preferably the same isotype as the IP antibody. Proteins detected equally in the specific IP and IgG control are likely to represent non-specific recovery.

Beads-only control

This identifies proteins that bind directly to the bead chemistry or matrix.

Positive interaction control

Where possible, include a known interacting protein pair or a condition known to promote the interaction. This helps distinguish a failed experiment from a true negative biological result.

Reciprocal Co-IP

Immunoprecipitate the prey and probe for the bait. Reciprocal recovery substantially strengthens confidence in a candidate interaction, especially when endogenous proteins are used.

How to interpret a Co-IP western blot

• The bait should be enriched in the specific IP compared with the IgG control.
• The prey should be enriched specifically in the bait IP and ideally absent or markedly lower in control IPs.
• Compare equivalent fractions of input and IP when making qualitative comparisons.
• Do not infer interaction strength solely from band intensity unless the workflow has been normalised and shown to operate in a suitable quantitative range.
• Antibody heavy and light chains can overlap with proteins near approximately 50 and 25 kDa. Cross-linked antibodies, light-chain-specific secondaries or TrueBlot-type detection systems can reduce this problem.

Co-IP for mass spectrometry

Discovery Co-IP–MS requires stricter background control than targeted western blotting. Use replicate experiments, matched IgG or tag controls, clean labware and MS-compatible reagents. Avoid keratin contamination and excessive antibody carryover. Consider antibody cross-linking to beads or tag-based capture if immunoglobulin-derived peptides dominate spectra.

Optimisation strategy

• Too little bait recovered: increase antibody amount, lysate input or binding time, or test an alternative antibody.
• Bait recovered but prey absent: reduce detergent or salt, shorten washes, keep samples colder, or consider whether the interaction is stimulus-dependent.
• High background: reduce antibody/bead excess, add pre-clearing, increase wash stringency gradually, or shorten incubation.
• Membrane protein: screen compatible detergents empirically rather than assuming NP-40/Triton conditions will preserve the complex.
• Nucleic-acid-mediated interaction: compare untreated lysate with DNase or RNase treatment to test whether the association depends on nucleic acid.
• Weak/transient interaction: consider a carefully optimised cross-linking approach, but recognise that cross-linking can introduce indirect associations and artefacts.

Recommendations and warnings

• Protect the interaction, not just the protein. A buffer that gives excellent total-protein extraction can still destroy the complex you want to measure.
• Optimise antibody and wash conditions separately. Too much antibody can increase background; overly stringent washing can erase a genuine weak interaction.
• Compare prey recovery only when bait recovery is comparable. Apparent biological differences can simply reflect unequal immunoprecipitation efficiency.
• Use nuclease treatment only as an experimental test. DNase or RNase can reveal DNA- or RNA-mediated association, but they can also alter complex stability.
• For endogenous Co-IP, reagent lot consistency matters. Antibody lots can differ in capture efficiency even when western blot signal looks similar.
• Use reciprocal Co-IP when possible. Recovering A with B and B with A is stronger evidence than a one-direction experiment alone.

Limitations

• Co-IP identifies biochemical association, not necessarily direct physical binding.
• Interactions can be lost during lysis and washing.
• Non-specific proteins can co-purify with beads or antibodies.
• Overexpression can create interactions not present at endogenous expression levels.
• Cross-linking can stabilise genuine transient interactions but can also capture proteins that are merely nearby.
• Comparisons between conditions require careful normalisation of input and IP efficiency.

Troubleshooting

Frequently asked questions

What is the difference between IP and Co-IP?

IP primarily enriches a specific target protein. Co-IP deliberately uses native conditions to recover the target together with associated proteins so protein complexes can be studied.

Should I use Protein A or Protein G beads?

It depends on the host species and antibody isotype. Check the bead manufacturer’s antibody-binding table. Protein A/G mixtures can simplify workflows when multiple antibody species are used.

How much antibody should I use?

Use the antibody supplier’s IP recommendation where available, then optimise empirically. Too little antibody reduces yield; excessive antibody can increase background and immunoglobulin contamination.

Can I quantify interaction strength by Co-IP?

Co-IP is primarily an enrichment assay. Semi-quantitative comparison is possible if input, IP efficiency and detection remain controlled, but absolute binding affinity requires other biophysical methods.

How can I validate a novel Co-IP interaction?

Use reciprocal Co-IP, orthogonal interaction assays, domain/mutation analysis and biological perturbations. For proteomic discoveries, reproduce the interaction in independent biological samples.

Does Co-IP prove a direct protein-protein interaction?

No. DNA, RNA or another protein can bridge bait and prey. A purified-protein pull-down, biophysical assay or structural method is needed to test direct binding more rigorously.

Why can a known interaction disappear in Co-IP?

Weak complexes can be disrupted by detergent, salt, dilution, long handling times or an antibody that sterically blocks the interaction surface.

Should I pre-clear lysate?

Pre-clearing can reduce background from bead- or IgG-binding proteins, but it can also remove low-abundance complexes. Treat it as an optimisation step rather than a mandatory rule.

How should Co-IP western blots be quantified?

Keep exposures unsaturated, verify comparable bait recovery, quantify prey relative to recovered bait where appropriate, and use biological replicates rather than technical repeats alone.

Related ABMIUM protocols

• Immunoprecipitation (IP) Protocol
• Pull-Down Assay Protocol
• Western Blot Protocol

References and primary methods

1. Gerace E, Moazed D. Coimmunoprecipitation of proteins from yeast. Methods Enzymol. 2014;541:13–26. PMID: 24674059.
2. Burckhardt CJ et al. Co-immunoprecipitation and semi-quantitative immunoblotting for analysis of protein-protein interactions. STAR Protocols. 2021. PMID: 34278331.
3. Lagundžin D et al. Optimized endogenous co-IP for protein-interaction analysis by LC-MS/MS. STAR Protocols. 2022. PMID: 35300004.

Relevant ABMIUM products

Co-IP requires an antibody that is genuinely compatible with immunoprecipitation. As a catalogue example, ABM452 Anti-Human CD44 Antibody is explicitly listed for WB, IHC-P, IF/ICC and IP; it is relevant only when CD44 is your bait or validation target. For a different target, browse primary antibodies and filter for IP evidence, or use Find your MATCH. For downstream confirmation, ABMIUM also carries calibrated prestained protein markers for western blot workflows.

Explore more with ABMIUM

For another bait or prey, use Find your MATCH to compare IP evidence and species reactivity, or explore IP-compatible antibodies. Related workflows: IP, Pull-Down and Western Blot.